Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

FDA Grants IND, Approves Trial Protocol of Inhaled Ampion for COVID-19

americanpharmaceuticalreviewSeptember 27, 2020

Tag: Ampio Pharmaceuticals , COVID-19 , Ampion , ARDS

PharmaSources Customer Service